Prostate specific antigen

Prostate specific antigen (PSA) is currently used as a tumour marker for prostate adenocarcinoma.

PSA is a 33 kilodalton glycoprotein produced in prostate epithelial cells. Its normal physiologic role is as a liquifying agent for seminal fluid and the normal amount in human serum is usually very low. Elevated serum levels of PSA have been associated with prostate carcinoma.

PSA can exist in the serum in two forms:

  • bound/complexed (to serum protein): elevated levels are associated with prostate cancer
  • free PSA (fPSA): elevated levels are associated with benign prostatic hyperplasia (BPH)

PSA levels

Although an increased PSA level is associated with prostate cancer, a low level cannot exclude prostate cancer. Although exact cut-off values are continually in flux, subject to the most recent data:

  • 2-4 ng/ml: 15-25% change in a man >50 years old of having prostate cancer
  • 4-10 ng/ml: imaging screening/biopsy indicated

The absolute level may also be misleading if there is a trend in the data upward (or downward) over time. Men with enlarged glands from BPH may also have elevated PSA levels. False-positive levels have been associated with

An upward trend in a patient's PSA value may also be concerning after a prostatectomy, and it may indicate recurrent or metastatic disease.

See also

Share article

Article information

rID: 43244
System: Urogenital
Section: Pathology
Synonyms or Alternate Spellings:
  • PSA
  • Prostate specific antigen (PSA)

Support Radiopaedia and see fewer ads

Updating… Please wait.
Loadinganimation

Alert accept

Error Unable to process the form. Check for errors and try again.

Alert accept Thank you for updating your details.